Rating Agencies
Share recommendations
Made with ❤ von BGFL
#BGFLapp * beta
Valuable background information and well-founded assessments of individual stocks are provided by the studies of the research houses. On this page, Boersengefluester.de (BGFL) provides an integrated overview of all analyst recommendations that come in via the EQS Group newsfeed - enriched with current stock charts as well as meaningful key figure tables and investor information from BGFL. Tip: You are also welcome to use the EQS newsfeed, which we have also enhanced with all the latest company news from our coverage universe.
13.12.2023 10:01AM
Study issued by First Berlin Equity Research GmbH
Haemato AG (von First Berlin Equity Research GmbH): Not Rated
Not Rated
First Berlin Equity Research hat ein Research Update zu Haemato AG (ISIN:
DE000A289VV1) veröffentlicht. Analyst Ellis Acklin hat seine bisherige
Buy-Empfehlung und sein bisheriges Kursziel von EUR 34,00 wegen des
bevorstehenden Delistings zurückgenommen.
Zusammenfassung:
Haemato wird die Notierung ihrer Aktien im Open Market der Frank [ … ]
13.12.2023 09:41AM
Study issued by First Berlin Equity Research GmbH
MPH Health Care AG (von First Berlin Equity Research GmbH): Kaufen
Kaufen
First Berlin Equity Research hat ein Research Update zu MPH Health Care AG
(ISIN: DE000A289V03) veröffentlicht. Analyst Ellis Acklin bestätigt seine
BUY-Empfehlung und bestätigt sein Kursziel von EUR 62,00.
Zusammenfassung:
Der NAVPS lag zum Neunmonatszeitpunkt bei €50,40 gegenüber €31,90 in 9M/22
(+58%) Die schlep [ … ]
05.12.2023 09:01AM
Study issued by NuWays AG
MAX Automation SE (von NuWays AG): BUY
BUY
Strong growth opportunities carried by structural trends; PT up
Despite a strong competitive quality and structural growth drivers, MAX
Automation had difficulties translating it into operating performance
between 2016 and 2020. Thanks to MAX having done its homework by adjusting
its portfolio and structural trends kicking in, shares look poise [ … ]
04.12.2023 09:01AM
Study issued by NuWays AG
Netfonds AG (von NuWays AG): BUY
BUY
FY23 guidance in reach after solid Q3 figures; chg
Netfonds published solid Q3 figures with further sequential top and bottom
line growth and confirmed its FY23 guidance. In detail:
Gross sales came in at € 48.4m (21% yoy, 4% qoq), broadly in line with our
estimate of € 49.0m. The sequential improvement is mainly driven by the
stron [ … ]
24.11.2023 09:27AM
Study issued by NuWays AG
NFON AG (von NuWays AG): BUY
BUY
Strong Q3 bottom-line leads to another upgrade; chg.
Yesterday, NFON released a strong set of Q3 results. While recurring
revenues were in line with our estimates, the company provided a
significant beat on the bottom line.
Q3 recurring revenues came in at € 19.4m, up 5.3% yoy (eNuW: € 19.4m) based
on a slightly increased seat base [ … ]
24.11.2023 09:26AM
Study issued by NuWays AG
UBM Development AG (von NuWays AG): BUY
BUY
Q3 displays ongoing transaction market standstill, chg.
Yesterday, UBM released another uninspiring set of quarterly results as the
real estate transaction market continues to be in a complete standstill as
volumes in Europe decreased another 16% qoq. Still, positive news came from
several building permits that were granted during the quarter.
[ … ]
24.11.2023 09:21AM
Study issued by NuWays AG
DEMIRE AG (von NuWays AG): HOLD
HOLD
Another guidance adjustment following lack of disposals; chg.
As already anticipated in our recent earnings review, DEMIRE yesterday
updated its FY guidance for a second time this year as management now
expects a lower number of property disposals than what was planned at the
beginning of the year. As this consequently results in a larger asset [ … ]
23.11.2023 09:02AM
Study issued by NuWays AG
USU Software AG (von NuWays AG): BUY
BUY
Final Q3 in line with est. amid sequential improvements; chg.
Yesterday, USU released a solid set of Q3 results, showing sequential
improvements compared to the second quarter despite an ongoing
underperformance of license revenues.
Q3 sales increased 4.2% qoq to € 32.9 (eNuW: € 33.3m), implying a muted 1%
yoy growth against a tough [ … ]
22.11.2023 09:01AM
Study issued by NuWays AG
ZEAL Network SE (von NuWays AG): BUY
BUY
Lucrative “Games” business metrics
In Q3, ZEAL’s games business showed first meaningful impacts, but more
importantly provided some tangible KPIs. Hence, we evaluate those metrics
to compare Games with Lottery.
New KPI 'Pay-Ins': ZEAL introduced this new KPI to better compare Lottery
and Games. Pay-in refers to the amount of [ … ]
20.11.2023 10:01AM
Study issued by GBC AG
Coreo AG (von GBC AG): BUY
BUY
H1 2023: Large portfolio acquisitions to come in 2024; EBIT break-even
expected in 2024; price target: € 1.00; rating: BUY
In the first six months of 2023, Coreo AG was able to increase rental
income to € 3.17 million (previous year: € 2.82 million). As there were no
property additions in both the 2022 financial year and the [ … ]
Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
We have summarised companies with a market capitalisation of more than EUR 1 billion that are not included in any index under X-Caps.
Dataselect Tool Family
boersengefluester.de · #BGFL
· © 2024
The news manufactory
Good luck with all your investments
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
Idea & concept: 3R Technologies 
boersengefluester.de GmbH
Copyright © 2024
by Gereon Kruse
#BGFL